Thomas Comptdaer
Impact in
- Neurology top 10%
- Parkinson's Disease Mechanisms and Treatments
- Neurological diseases and metabolism
- Neuroinflammation and Neurodegeneration Mechanisms
-
- Nuclear Receptors and Signaling
- Genetic Neurodegenerative Diseases
Papers in
-
- Advanced biosensing and bioanalysis techniques 1
- Metabolism, Diabetes, and Cancer 1
- Histone Deacetylase Inhibitors Research 1
- Protein Degradation and Inhibitors 1
-
- Parkinson's Disease Mechanisms and Treatments 5
- Neurological diseases and metabolism 2
- Neuroinflammation and Neurodegeneration Mechanisms 1
- Co-authors
- Marie‐Christine Chartier‐Harlin (6 shared papers)Eugénie Mutez (5 shared papers)Martin Figeac (3 shared papers)A. Destée (5 shared papers)S. Bleuse (2 shared papers)Céline Villenet (2 shared papers)Frédéric Leprêtre (2 shared papers)Karim Bélarbi (2 shared papers)
- Journals
- Neurobiology of Disease (2 papers)Brain Pathology (1 paper)Cancers (1 paper)Frontiers in Cell and Developmental Biology (1 paper)Journal of Neuroinflammation (1 paper)
- Partner nations
- FranceNetherlandsUnited States
In The Last Decade
Thomas Comptdaer
11 papers receiving 196 citations
Peers
Comparison fields: 5 of 48
- Neurology 98
- Neurology 43
- Cellular and Molecular Neuroscience 55
- Biological Psychiatry 5
- Cell Biology 32
Countries citing papers authored by Thomas Comptdaer
This map shows the geographic impact of Thomas Comptdaer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Comptdaer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Comptdaer more than expected).
Fields of papers citing papers by Thomas Comptdaer
This network shows the impact of papers produced by Thomas Comptdaer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Comptdaer. The network helps show where Thomas Comptdaer may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Comptdaer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 53 | |
| 2 | 2020 | 51 | |
| 3 | 2019 | 21 | |
| 4 | 2018 | 17 | |
| 5 | 2021 | 13 | |
| 6 | 2022 | 12 | |
| 7 | 2016 | 11 | |
| 8 | 2023 | 8 | |
| 9 | 2022 | 6 | |
| 10 | 2024 | 4 | |
| 11 | 2015 | 1 |
About Thomas Comptdaer
Thomas Comptdaer is a scholar working on Molecular Biology, Neurology, Neurology, Physiology and Cellular and Molecular Neuroscience, having authored 11 papers that have together received 197 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (5 papers), Neurological diseases and metabolism (2 papers), Alzheimer's disease research and treatments (2 papers), Advanced biosensing and bioanalysis techniques (1 paper), Metabolism, Diabetes, and Cancer (1 paper), Neuroinflammation and Neurodegeneration Mechanisms (1 paper), Histone Deacetylase Inhibitors Research (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Neurology (98 citations), Neurology (43 citations), Cellular and Molecular Neuroscience (55 citations), Biological Psychiatry (5 citations) and Cell Biology (32 citations). Thomas Comptdaer has collaborated with scholars based in France, Netherlands and United States. Frequent co-authors include Marie‐Christine Chartier‐Harlin, Eugénie Mutez, Martin Figeac, A. Destée, S. Bleuse, Céline Villenet, Frédéric Leprêtre, Karim Bélarbi, Christel Vanbesien-Mailliot and Boudewijn P. F. Lelieveldt. Their work appears in journals such as Neurobiology of Disease, Brain Pathology, Cancers, Frontiers in Cell and Developmental Biology and Journal of Neuroinflammation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.